NPPA unable to regulate remdesivir sale
POST FORWARDED
July 29, 2020
NEW DELHI: India has not set a price for anti-viral remdesivir because it has been approved only as an experimental therapy for Covid-19, le...
Read more
from Economic Times https://ift.tt/CLSZ8k4